Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@Reuters_Health](/creator/twitter/Reuters_Health)
"Denmark's Genmab has agreed to acquire Merus NV a Nasdaq-listed Dutch biotech firm developing a head-and-neck cancer drug for $X billion in cash the two companies said on Monday"  
[X Link](https://x.com/Reuters_Health/status/1972534320611950665) [@Reuters_Health](/creator/x/Reuters_Health) 2025-09-29T05:30Z 253.5K followers, 1375 engagements


"AstraZeneca and Daiichi Sankyo's precision drug Datroway improved survival prospects in patients with an advanced form of breast cancer in a late-stage trial the drugmakers said on Monday paving the way for broader approvals"  
[X Link](https://x.com/Reuters_Health/status/1975222149238382856) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-06T15:30Z 253.5K followers, XXX engagements


"CBC Group Asia's largest healthcare-focused asset manager has raised $XXX million for its second R-Bridge Healthcare Fund making it the region's biggest healthcare private credit fund the company said on Wednesday"  
[X Link](https://x.com/Reuters_Health/status/1978396740907585806) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-15T09:45Z 253.5K followers, XXX engagements


"Novartis said on Thursday its Fabhalta drug was shown to meaningfully slow the progression of a rare type of kidney disease under final results of a late-stage trial"  
[X Link](https://x.com/Reuters_Health/status/1978698719508804022) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-16T05:45Z 253.5K followers, XXX engagements


"Novartis said on Thursday its Fabhalta drug was shown to meaningfully slow the progression of a rare type of kidney disease under final results of a late-stage trial"  
[X Link](https://x.com/Reuters_Health/status/1978763042285297991) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-16T10:00Z 253.5K followers, XXX engagements


"Novartis said on Thursday its Fabhalta drug was shown to meaningfully slow the progression of a rare type of kidney disease under final results of a late-stage trial"  
[X Link](https://x.com/Reuters_Health/status/1978827112606753065) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-16T14:15Z 253.5K followers, XXX engagements


"AstraZeneca and Daiichi Sankyo's new breast cancer drug helped significantly extend survival in some patients in a late-stage trial marking a potential breakthrough in one of the hardest-to-treat forms of the disease"  
[X Link](https://x.com/Reuters_Health/status/1979800960340824217) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T06:45Z 253.5K followers, XXX engagements


"Namibia's ministry of health and social services on Sunday declared an outbreak of mpox in the city of Swakopmund"  
[X Link](https://x.com/Reuters_Health/status/1979902928862253222) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T13:30Z 253.5K followers, XXX engagements


"Datroway's success could position it to compete more directly with Gilead's Trodelvy"  
[X Link](https://x.com/Reuters_Health/status/1979906657392918605) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T13:45Z 253.5K followers, XXX engagements


"Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death in patients with prostate cancer by 28%"  
[X Link](https://x.com/Reuters_Health/status/1979929303996342570) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T15:15Z 253.5K followers, XXX engagements


"Namibia's ministry of health and social services on Sunday declared an outbreak of mpox in the city of Swakopmund"  
[X Link](https://x.com/Reuters_Health/status/1979967047036469611) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T17:45Z 253.5K followers, XXX engagements


"Datroway's success could position it to compete more directly with Gilead's Trodelvy"  
[X Link](https://x.com/Reuters_Health/status/1979971017528263079) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T18:00Z 253.5K followers, XXX engagements


"Namibia's ministry of health and social services on Sunday declared an outbreak of mpox in the city of Swakopmund"  
[X Link](https://x.com/Reuters_Health/status/1980031406739702090) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T22:00Z 253.5K followers, XXX engagements


"Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death in patients with prostate cancer by 28%"  
[X Link](https://x.com/Reuters_Health/status/1980057651183599831) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T23:45Z 253.5K followers, XXX engagements


"AstraZeneca and Daiichi Sankyo's drug Enhertu has shown strong results in two pivotal studies in the early stage of a certain type of breast cancer according to data announced on Saturday"  
[X Link](https://x.com/Reuters_Health/status/1979559366362620254) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-18T14:45Z 253.5K followers, XXX engagements


"Japan's Takeda Pharmaceutical Co has signed a deal with Innovent Biologics to accelerate development of the Chinese drugmaker's oncology medicines it said on Wednesday"  
[X Link](https://x.com/Reuters_Health/status/1981020351346684390) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-22T15:30Z 253.5K followers, XXX engagements


"From Breakingviews - How Credit Suisse's CoCos could rise from the dead"  
[X Link](https://x.com/Reuters_Health/status/1979215982867398901) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-17T16:00Z 253.5K followers, XXX engagements


"Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death in patients with prostate cancer by 28%"  
[X Link](https://x.com/Reuters_Health/status/1979993528093606343) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T19:30Z 253.5K followers, 1047 engagements


"Swedish medical equipment maker Getinge beat quarterly earnings expectations on Tuesday aided by price hikes and cost saving measures meant to combat a hit from U.S. tariffs and negative currency exchange effects"  
[X Link](https://x.com/Reuters_Health/status/1980586164969992436) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-21T10:45Z 253.5K followers, XXX engagements


"Swedish medical equipment maker Getinge beat quarterly earnings expectations on Tuesday aided by price hikes and cost saving measures meant to combat a hit from U.S. tariffs and negative currency exchange effects"  
[X Link](https://x.com/Reuters_Health/status/1980650475926999291) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-21T15:00Z 253.5K followers, XXX engagements


"Japan's Takeda Pharmaceutical Co has signed a deal with Innovent Biologics to accelerate development of the Chinese drugmaker's oncology medicines it said on Wednesday"  
[X Link](https://x.com/Reuters_Health/status/1981084445277897215) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-22T19:45Z 253.5K followers, XXX engagements


"From Breakingviews - How Credit Suisse's CoCos could rise from the dead"  
[X Link](https://x.com/Reuters_Health/status/1979151681876086833) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-17T11:45Z 253.5K followers, XXX engagements


"Swedish medical equipment maker Getinge reported third-quarter core earnings above market expectations on Tuesday supported by price adjustments to combat a hit from U.S. tariffs and negative currency exchange effects"  
[X Link](https://x.com/Reuters_Health/status/1980522004433269244) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-21T06:30Z 253.5K followers, XXX engagements


"China's Innovent Biologics said on Wednesday it had signed an $XXXX billion deal with Japan's Takeda Pharmaceutical Co to accelerate the development of its immuno-oncology and antibody-drug conjugate cancer therapies"  
[X Link](https://x.com/Reuters_Health/status/1980797555605749816) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-22T00:45Z 253.5K followers, XXX engagements


"WATCH: US family health insurance premiums jump X% to nearly $27000 in 2025 driven by higher spending on weight-loss treatments and prescriptions KFF reports. Workers pay $6850 on average with employers covering the rest"  
[X Link](https://x.com/Reuters_Health/status/1981174987873542505) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-23T01:45Z 253.5K followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Reuters_Health "Denmark's Genmab has agreed to acquire Merus NV a Nasdaq-listed Dutch biotech firm developing a head-and-neck cancer drug for $X billion in cash the two companies said on Monday"
X Link @Reuters_Health 2025-09-29T05:30Z 253.5K followers, 1375 engagements

"AstraZeneca and Daiichi Sankyo's precision drug Datroway improved survival prospects in patients with an advanced form of breast cancer in a late-stage trial the drugmakers said on Monday paving the way for broader approvals"
X Link @Reuters_Health 2025-10-06T15:30Z 253.5K followers, XXX engagements

"CBC Group Asia's largest healthcare-focused asset manager has raised $XXX million for its second R-Bridge Healthcare Fund making it the region's biggest healthcare private credit fund the company said on Wednesday"
X Link @Reuters_Health 2025-10-15T09:45Z 253.5K followers, XXX engagements

"Novartis said on Thursday its Fabhalta drug was shown to meaningfully slow the progression of a rare type of kidney disease under final results of a late-stage trial"
X Link @Reuters_Health 2025-10-16T05:45Z 253.5K followers, XXX engagements

"Novartis said on Thursday its Fabhalta drug was shown to meaningfully slow the progression of a rare type of kidney disease under final results of a late-stage trial"
X Link @Reuters_Health 2025-10-16T10:00Z 253.5K followers, XXX engagements

"Novartis said on Thursday its Fabhalta drug was shown to meaningfully slow the progression of a rare type of kidney disease under final results of a late-stage trial"
X Link @Reuters_Health 2025-10-16T14:15Z 253.5K followers, XXX engagements

"AstraZeneca and Daiichi Sankyo's new breast cancer drug helped significantly extend survival in some patients in a late-stage trial marking a potential breakthrough in one of the hardest-to-treat forms of the disease"
X Link @Reuters_Health 2025-10-19T06:45Z 253.5K followers, XXX engagements

"Namibia's ministry of health and social services on Sunday declared an outbreak of mpox in the city of Swakopmund"
X Link @Reuters_Health 2025-10-19T13:30Z 253.5K followers, XXX engagements

"Datroway's success could position it to compete more directly with Gilead's Trodelvy"
X Link @Reuters_Health 2025-10-19T13:45Z 253.5K followers, XXX engagements

"Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death in patients with prostate cancer by 28%"
X Link @Reuters_Health 2025-10-19T15:15Z 253.5K followers, XXX engagements

"Namibia's ministry of health and social services on Sunday declared an outbreak of mpox in the city of Swakopmund"
X Link @Reuters_Health 2025-10-19T17:45Z 253.5K followers, XXX engagements

"Datroway's success could position it to compete more directly with Gilead's Trodelvy"
X Link @Reuters_Health 2025-10-19T18:00Z 253.5K followers, XXX engagements

"Namibia's ministry of health and social services on Sunday declared an outbreak of mpox in the city of Swakopmund"
X Link @Reuters_Health 2025-10-19T22:00Z 253.5K followers, XXX engagements

"Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death in patients with prostate cancer by 28%"
X Link @Reuters_Health 2025-10-19T23:45Z 253.5K followers, XXX engagements

"AstraZeneca and Daiichi Sankyo's drug Enhertu has shown strong results in two pivotal studies in the early stage of a certain type of breast cancer according to data announced on Saturday"
X Link @Reuters_Health 2025-10-18T14:45Z 253.5K followers, XXX engagements

"Japan's Takeda Pharmaceutical Co has signed a deal with Innovent Biologics to accelerate development of the Chinese drugmaker's oncology medicines it said on Wednesday"
X Link @Reuters_Health 2025-10-22T15:30Z 253.5K followers, XXX engagements

"From Breakingviews - How Credit Suisse's CoCos could rise from the dead"
X Link @Reuters_Health 2025-10-17T16:00Z 253.5K followers, XXX engagements

"Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death in patients with prostate cancer by 28%"
X Link @Reuters_Health 2025-10-19T19:30Z 253.5K followers, 1047 engagements

"Swedish medical equipment maker Getinge beat quarterly earnings expectations on Tuesday aided by price hikes and cost saving measures meant to combat a hit from U.S. tariffs and negative currency exchange effects"
X Link @Reuters_Health 2025-10-21T10:45Z 253.5K followers, XXX engagements

"Swedish medical equipment maker Getinge beat quarterly earnings expectations on Tuesday aided by price hikes and cost saving measures meant to combat a hit from U.S. tariffs and negative currency exchange effects"
X Link @Reuters_Health 2025-10-21T15:00Z 253.5K followers, XXX engagements

"Japan's Takeda Pharmaceutical Co has signed a deal with Innovent Biologics to accelerate development of the Chinese drugmaker's oncology medicines it said on Wednesday"
X Link @Reuters_Health 2025-10-22T19:45Z 253.5K followers, XXX engagements

"From Breakingviews - How Credit Suisse's CoCos could rise from the dead"
X Link @Reuters_Health 2025-10-17T11:45Z 253.5K followers, XXX engagements

"Swedish medical equipment maker Getinge reported third-quarter core earnings above market expectations on Tuesday supported by price adjustments to combat a hit from U.S. tariffs and negative currency exchange effects"
X Link @Reuters_Health 2025-10-21T06:30Z 253.5K followers, XXX engagements

"China's Innovent Biologics said on Wednesday it had signed an $XXXX billion deal with Japan's Takeda Pharmaceutical Co to accelerate the development of its immuno-oncology and antibody-drug conjugate cancer therapies"
X Link @Reuters_Health 2025-10-22T00:45Z 253.5K followers, XXX engagements

"WATCH: US family health insurance premiums jump X% to nearly $27000 in 2025 driven by higher spending on weight-loss treatments and prescriptions KFF reports. Workers pay $6850 on average with employers covering the rest"
X Link @Reuters_Health 2025-10-23T01:45Z 253.5K followers, XXX engagements

creator/twitter::25562183/posts
/creator/twitter::25562183/posts